Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 3, Pages 771-778
Publisher
Wiley
Online
2013-02-07
DOI
10.1002/ijc.28072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Splenic Stromal Microenvironment Negatively Regulates Virus-Activated Plasmacytoid Dendritic Cells through TGF-
- (2014) L. Li et al. JOURNAL OF IMMUNOLOGY
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
- (2012) Sana Intidhar Labidi-Galy et al. OncoImmunology
- Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
- (2011) Boris Reizis et al. Annual Review of Immunology
- Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
- (2011) Trine O. Jensen et al. CANCER
- Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
- (2011) S. I. Labidi-Galy et al. CANCER RESEARCH
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The dendritic cell–tumor cross-talk in cancer
- (2010) Yuting Ma et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis
- (2009) C. Domschke et al. CANCER RESEARCH
- Tumour-derived prostaglandin E2and transforming growth factor-β synergize to inhibit plasmacytoid dendritic cell-derived interferon-α
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transforming growth factor-beta: A target for cancer therapy
- (2009) Ronan J. Kelly et al. Journal of Immunotoxicology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started